Provided by Tiger Trade Technology Pte. Ltd.

Petros Pharmaceuticals, Inc.

0.0080
0.0000
Volume:117.54K
Turnover:940.18
Market Cap:338.98K
PE:0.00
High:0.0081
Open:0.0080
Low:0.0072
Close:0.0080
52wk High:5.75
52wk Low:0.0017
Shares:42.37M
Float Shares:42.29M
Volume Ratio:0.74
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2061
EPS(LYR):-83.4693
ROE:-565.29%
ROA:-48.91%
PB:0.10
PE(LYR):0.00

Loading ...

Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Major Issues Report

Form 8-K - Current report
Dec 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 16, 2023

Correspondence

Form CORRESP - Correspondence
Sep 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 30, 2022

Major Issues Report

8-K - Current report
Nov 15, 2022

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]